Long-term tumor control following gamma-knife radiosurgery of recurrent or residual pituitary adenomas: a population-based cohort study
2024

Long-term tumor control after gamma-knife surgery for pituitary adenomas

Sample size: 147 publication 10 minutes Evidence: moderate

Author Information

Author(s): Gabri Alexander, Lindberg Felicia, Kristiansson Helena, Gubanski Michael, Höybye Charlotte, Olsson Martin, Förander Petter, Skyrman Simon, Lippitz Bodo, Fletcher-Sandersjöö Alexander, Bartek Jiri

Primary Institution: Karolinska University Hospital

Hypothesis

The study aims to evaluate the long-term efficacy of gamma knife radiosurgery for recurrent or residual pituitary adenomas.

Conclusion

Gamma knife radiosurgery is an effective treatment for recurrent or residual pituitary adenomas, providing substantial long-term control, although there is a notable risk of adverse radiation events.

Supporting Evidence

  • 147 patients were included in the study with a median follow-up time of 8.1 years.
  • The 5-year and 10-year progression-free survival rates were 86% and 68%, respectively.
  • Somatotrophic adenomas had a significantly lower risk of tumor progression.
  • Hypopituitarism was the most common adverse radiation event, affecting 32% of patients.

Takeaway

Doctors used a special type of surgery called gamma knife radiosurgery to help patients with certain brain tumors, and it worked well for a long time, but some patients had side effects.

Methodology

This was a population-based, observational cohort study of patients who underwent gamma knife radiosurgery for postoperative residual or recurrent pituitary adenomas between 1999 and 2020.

Potential Biases

Potential bias due to the retrospective nature of the study and reliance on neuroradiologist assessments for tumor progression.

Limitations

The study may have selection bias due to excluding patients outside the Stockholm region, which limits generalizability.

Participant Demographics

The cohort had a median age of 52 years, with a balanced sex distribution and 44% having functioning pituitary adenomas.

Statistical Information

P-Value

0.003

Confidence Interval

95% CI: 80 – 92%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1007/s00701-024-06380-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication